Patient-reported treatment burden of chronic immune thrombocytopenia therapies

BACKGROUND: Chronic immune thrombocytopenia (ITP) is a debilitating autoimmune disorder that causes a reduction in blood platelets and increased risk of bleeding. ITP is currently managed with various pharmacologic therapies and splenectomy. This study was conducted to assess patient perceived and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, T Michelle, Horblyuk, Ruslan V, Grotzinger, Kelly M, Matzdorff, Axel C, Pashos, Chris L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350461/
https://www.ncbi.nlm.nih.gov/pubmed/22436142
http://dx.doi.org/10.1186/1471-2326-12-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350461/
https://www.ncbi.nlm.nih.gov/pubmed/22436142
http://dx.doi.org/10.1186/1471-2326-12-2

Ejemplares similares